Back to User profile » Dr Zhenwei Yu
Papers published by Dr Zhenwei Yu:
Efficacy and Safety of Clobazam Adjunctive Therapy in Pediatric Patients with Drug-Resistant Epilepsy
Yu L, Chen S, Zhang Z, Hu Y, Fang Y, Mao F, Wang S, Yu Z, Li X, Dai H
Drug Design, Development and Therapy 2025, 19:10899-10908
Published Date: 9 December 2025
Population Pharmacokinetics of Tigecycline and Implications for Individualized Therapy Optimization: A Systematic Review
Dai A, Zheng F, Liu J, Chen Q, Zhou Z, Yu L, Yu Z, Guan Y
Drug Design, Development and Therapy 2025, 19:10045-10060
Published Date: 11 November 2025
Development and Validation of a Population Pharmacokinetics Model of Perampanel for Pediatric Epilepsy Patients for Optimized Dosing
Yu L, Mao F, Chen S, Liu J, Xiao J, Chen M, Luo H, Yu Z, Dai H
Drug Design, Development and Therapy 2025, 19:3119-3128
Published Date: 23 April 2025
Prescribing Trends of Fixed-Dose Combination Antibiotics Not Recommended by the WHO (FNRs) for ICU Patients in Six Major Areas of China During a Seven-Year Period
Zhou L, Zhao Y, Zhu J, Liu J, Liang G, Yang Y, Han G, Yu Z
Drug Design, Development and Therapy 2024, 18:5781-5791
Published Date: 6 December 2024
Population Pharmacokinetics of Tigecycline for Critically Ill Patients Undergoing Continuous Renal Replacement Therapy
Song S, Liu J, Su W, Yu H, Feng B, Wu Y, Guo F, Yu Z
Drug Design, Development and Therapy 2024, 18:4459-4469
Published Date: 5 October 2024
Adequacy of the Dosing and Infusion Time of Ceftazidime/Avibactam for the Treatment of Gram-Negative Bacterial Infections: A PK/PD Simulation Study
Han Y, Zhu J, Liu J, Zheng Y, Liang G, Yang Y, Yu L, Yu Z, Han G
Infection and Drug Resistance 2024, 17:2823-2832
Published Date: 8 July 2024
Model-Informed Precision Dosing of Imipenem in an Obese Adolescent Patient with Augmented Renal Clearance and History of Schizophrenia
Chen Y, Han Y, Guo F, Yu Z
Infection and Drug Resistance 2024, 17:761-767
Published Date: 27 February 2024